Stockscreener 앱 받기
304.42
2.03%
6.6969
전일 마감가:
$297.72
열려 있는:
$300.2
하루 거래량:
82,909
Relative Volume:
0.34
시가총액:
$6.69B
수익:
$2.58B
순이익/손실:
$-778.69M
주가수익비율:
-11.14
EPS:
-27.33
순현금흐름:
$223.75M
1주 성능:
-1.75%
1개월 성능:
+8.36%
6개월 성능:
+23.58%
1년 성능:
-9.84%
1일 변동 폭
$297.57
$305.03
1주일 범위
$292.56
$311.43
52주 변동 폭
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
명칭
Bio Rad Laboratories Inc
전화
(510) 724-7000
주소
1000 ALFRED NOBEL DRIVE, HERCULES
BIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
304.01 | 8.06B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
132.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.66 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.41 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.99 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.28 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-06-16 | 개시 | Wells Fargo | Overweight |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-01-28 | 재확인 | Citigroup | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2018-10-17 | 개시 | Goldman | Buy |
| 2018-09-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2018-02-16 | 다운그레이드 | CL King | Buy → Neutral |
| 2017-07-13 | 개시 | Wells Fargo | Outperform |
| 2017-06-28 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Hold |
| 2016-10-13 | 개시 | CL King | Buy |
| 2015-05-06 | 재확인 | Jefferies | Buy |
| 2009-12-18 | 개시 | Maxim Group | Buy |
| 2009-11-06 | 개시 | Jefferies & Co | Buy |
| 2009-07-17 | 개시 | Soleil | Buy |
| 2007-09-26 | 개시 | Banc of America Sec | Buy |
| 2007-02-23 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Top chart patterns to watch in Bio Rad Laboratories Inc.Wall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
Is Bio Rad Laboratories Inc. a candidate for recovery playGap Up & Weekly Momentum Stock Picks - newser.com
Does Bio Rad Laboratories Inc. qualify in momentum factor screeningQuarterly Trade Review & Reliable Breakout Forecasts - newser.com
Is Bio Rad Laboratories Inc. stock a bargain at current levelsRate Cut & Free Fast Gain Swing Trade Alerts - newser.com
Hydroxyapatite Market to Witness Significant Growth from 2025 - openPR.com
Using Bollinger Bands to evaluate Bio Rad Laboratories Inc.Weekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com
How buyback programs support Bio Rad Laboratories Inc. Class B stockJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
What institutional flow reveals about Bio Rad Laboratories Inc.Trade Exit Summary & High Return Trade Opportunity Guides - newser.com
Sivik Global Healthcare LLC Makes New Investment in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Can Bio Rad Laboratories Inc. (BUW) stock resist broad market declinesJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 15.3%Here's What Happened - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap UpWhat's Next? - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Shares Sold by DAVENPORT & Co LLC - MarketBeat
KnowItAll Spectroscopy Software | Bio-Rad Laboratories Inc., Informatics Div. | New Products - Photonics Spectra
Will Bio Rad Laboratories Inc. (BUW) stock gain from lower interest ratesOil Prices & Reliable Entry Point Trade Alerts - newser.com
Can technical indicators confirm Bio Rad Laboratories Inc.’s reversalAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Will Bio Rad Laboratories Inc. see short term momentumJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Newborn Screening Market Huge Growth in Future Scope 2025-2032 | Agilent Technologies, Inc., Bio-rad laboratories, Inc. - industrytoday.co.uk
Published on: 2025-10-10 05:39:23 - newser.com
Why Bio Rad Laboratories Inc. stock is favored by pension funds2025 Technical Overview & Fast Momentum Stock Entry Tips - newser.com
Market reaction to Bio Rad Laboratories Inc.’s recent newsPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
945 Shares in Bio-Rad Laboratories, Inc. $BIO Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat
Will Bio Rad Laboratories Inc. Class stock outperform value peers2025 Sector Review & High Yield Stock Recommendations - newser.com
Why Bio Rad Laboratories Inc. Class B stock is a strong analyst pickWeekly Volume Report & AI Powered Market Entry Ideas - newser.com
Published on: 2025-10-09 05:47:16 - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock nearing a technical breakoutPortfolio Value Report & Free Accurate Trade Setup Notifications - newser.com
Bio-Rad Extends Partnership with Gencurix Through Strategic Agreement for Droplet Digital PCR IVD Oncology Kits in Europe - the-scientist.com
Future of Polymerase Chain Reaction (PCR) Market Growth - openPR.com
Liquid Handling Systems Market Size, Scope 2032 by Key - openPR.com
Exploring the Potential of Chromatography Resins in Therapeutic Treatment Delivery - BioProcess International
Real-Time PCR And Digital PCR Market Size, Trends Analysis 2032 - openPR.com
United States Next Generation Sequencing Market Size, Trends & - openPR.com
A Look at Bio-Rad Laboratories’s Valuation Following Precision Medicine Push and New ddPCR Platform Launches - Sahm
Life Sciences Tools Market Size, Dynamics 2031 by Major - openPR.com
How Bio Rad Laboratories Inc. Class stock trades pre earningsJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock stays resilientMarket Weekly Review & High Conviction Buy Zone Picks - newser.com
What market sentiment indicators show for Bio Rad Laboratories Inc. (BUWA) stock2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Is Bio Rad Laboratories Inc. Class stock a top dividend aristocrat candidateBond Market & Safe Capital Growth Tips - newser.com
Why Bio Rad Laboratories Inc. Class B stock appears on watchlistsJuly 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock protected from inflationTrend Reversal & Verified Technical Signals - newser.com
Can Bio-Rad (BIO) Sustain Innovation Momentum After Leadership Loss and Diagnostics Expansion? - Sahm
(PDF) New insights into the sensitivity of Immulab reagent red blood cells compared to Bio-Rad, Grifols and QuidelOrtho - researchgate.net
Public Employees Retirement System of Ohio Increases Stake in Bio-Rad Laboratories, Inc. $BIO - Defense World
Liquid Chromatography Instruments Market Size & Strategic - openPR.com
Vector Purification Market Research, Industry Trends & Global Forecasts, 2035, Profiles of Agilent, BIA Separations, Bio-Rad, BioVision, Cytiva, Merck, Sartorius, Takara Bio, Thermo Fisher ScientificResearchAndMarkets.com - Business Wire
United States Multiplexed Diagnostics Market Share, Trends, - openPR.com
Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe - News-Medical
Bio Rad Laboratories Inc (BIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bio Rad Laboratories Inc 주식 (BIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lakkaraju Roop Kalyan | EVP, Chief Financial Officer |
Sep 06 '25 |
Option Exercise |
0.00 |
1,535 |
0 |
2,394 |
| COREY COLLEEN | EVP, Global Human Resources |
Sep 06 '25 |
Option Exercise |
0.00 |
576 |
0 |
19,759 |
| BARRY JAMES | EVP, President, LSG |
Sep 06 '25 |
Option Exercise |
0.00 |
1,056 |
0 |
1,588 |
| Allison Schwartz | Director |
Sep 06 '25 |
Option Exercise |
0.00 |
92 |
0 |
1,489 |
| ENGELHARDT EVA ANETTE | EVP, President, CDG |
Sep 06 '25 |
Option Exercise |
0.00 |
1,152 |
0 |
1,309 |
| ENLOE COURTNEY C | EVP, General Counsel & Sec |
Sep 06 '25 |
Option Exercise |
0.00 |
768 |
0 |
904 |
| SCHWARTZ NORMAN D | Chairman & CEO |
Sep 06 '25 |
Option Exercise |
0.00 |
3,455 |
0 |
444,962 |
| Allison Schwartz | Director |
Sep 01 '25 |
Option Exercise |
0.00 |
147 |
0 |
1,452 |
| BARRY JAMES | EVP, President, LSG |
Sep 01 '25 |
Option Exercise |
0.00 |
602 |
0 |
749 |
| COREY COLLEEN | EVP, Global Human Resources |
Sep 01 '25 |
Option Exercise |
0.00 |
1,102 |
0 |
19,581 |
0.40%
0.92%
자본화:
|
볼륨(24시간):